Biogen Inc.
Biogen Inc. logo
BIIB

Biogen Inc. (BIIB)

$301.851.09%

Market is closed
– opens on 8 PM, 02 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$299.18
Day's Range
$306.125
$187.16
52-Week Range
$311.88
1 month return8.43%
3 month return53.98%
1 year return32.09%
5 year return4.9%

Company Information

At Biogen, mission is clear: company is pioneer in neuroscience. Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. One of the world's first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, commercializes biosimilars of advanced biologics and is focused on advancing research programs in multiple sclerosis and neuroimmunology, Alzheimer's disease and dementia, neuromuscular disorders, movement disorders, ophthalmology, neuropsychiatry, immunology, acute neurology and neuropathic pain.
OrganizationBiogen Inc.
Employees9610
CEOMr. Michael R. McDonnell CPA
IndustryHealth Technology

Analyst Recommendation

based on 33 analysts ratings

Hold
36%
Buy
48%
Hold
15%
Sell

Based on 33 Wall street analysts offering stock ratings for Biogen Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 3.13%

Current

$301.85

Target

$311.3

Recommendation Trend

Based on 33 analyst

Current1M Ago3M Ago
Buy
12
22
19
Hold
16
18
21
Sell
5
0
0
Consensus
HOLD
BUY
HOLD

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
43.9B
Book Value
$88.72
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
19.54
PE Ratio
15.62
PEG Ratio
38.21
Wall Street Target Price
311.3

Valuation

Trailing PE15.62
Forward PE19.49
Price/Book (mrq)
3.44
Enterprise Value
45.7B
Enterprise Value/Revenue
4.41
Enterprise Value/Ebitda
10.91

Technicals

Beta
0.19
50 Day MA
269.61
200 Day MA
223.02

Sustainability

Rating Date2019-01-01
Total Esg
22.95
Total Esg Percentile
33.82
Environment Score1.02
Environment Score Percentile2.0
Social Score13.48
Social Score Percentile2.0
Governance Score7.45
GovernanceScorePercentile2.0
Controversy Level2.0

Institutional Holdings

PRIMECAP Management Company

10.93%

Vanguard Group Inc

8.27%

State Street Corporation

4.79%

Wellington Management Company LLP

3.57%

Geode Capital Management, LLC

2.25%

JPMorgan Chase & Co

1.37%

Discover more

Frequently Asked Questions

What is Biogen Inc. share price today?

Can Indians buy Biogen Inc. shares?

How can I buy Biogen Inc. shares from India?

Can Fractional shares of Biogen Inc. be purchased?

What are the documents required to start investing in Biogen Inc. stocks?

What are today’s High and Low prices of Biogen Inc.?

What are today’s traded volumes of Biogen Inc.?

What is today’s market capitalisation of Biogen Inc.?

What is the 52 Week High and Low Range of Biogen Inc.?

How much percentage Biogen Inc. is down from its 52 Week High?

How much percentage Biogen Inc. is up from its 52 Week low?

What are the historical returns of Biogen Inc.?

Who is the Chief Executive Officer (CEO) of Biogen Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*